Scarica l'app Stockscreener
0.5231
0.60%
0.0031
Dopo l'orario di chiusura:
.52
-0.0031
-0.59%
Precedente Chiudi:
$0.52
Aprire:
$0.5243
Volume 24 ore:
97,344
Relative Volume:
0.68
Capitalizzazione di mercato:
$73.27M
Reddito:
$133.93M
Utile/perdita netta:
$4.97M
Rapporto P/E:
15.66
EPS:
0.0334
Flusso di cassa netto:
$10.12M
1 W Prestazione:
-6.59%
1M Prestazione:
+8.98%
6M Prestazione:
-30.83%
1 anno Prestazione:
+3.66%
Intervallo 1D:
$0.515
$0.5752
Intervallo di 1 settimana:
$0.515
$0.5923
Portata 52W:
$0.438
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Nome
Xtant Medical Holdings Inc
Settore
Industria
Telefono
406-388-0480
Indirizzo
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.5231 | 72.84M | 133.93M | 4.97M | 10.12M | 0.0334 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-05 | Iniziato | BTIG Research | Buy |
| 2018-11-15 | Reiterato | Maxim Group | Buy |
| 2018-02-14 | Reiterato | Maxim Group | Buy |
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
MSN Money - MSN
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - Orthopedics This Week
May 13 before trading: Xtant Medical posts Q1 results, 8:30 ET call - Stock Titan
Xtant Medical launches Trivium Shaped allograft for surgeries - Yahoo Finance
Xtant Medical launches pre-shaped bone graft product line - Investing.com UK
Xtant Medical launches pre-shaped bone graft product line By Investing.com - Investing.com Australia
Xtant rolls out ready-to-use bone graft forms for spine surgery - Stock Titan
Xtant Medical Holdings (XTNT) price target increased by 12.12% to 1.26 - MSN
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat - MSN
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 67.8% in April - MarketBeat
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire) - Aktiellt
Xtant (XTNT) Stock Prediction | Xtant Medical posts 100% EPS surprise, beats loss estimatesTrending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
Xtant (XTNT) Stock: Risks and Growth Potential | Q4 2025: Earnings Beat EstimatesOperating Income - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Xtant Medical (XTNT): Buy Rating and Growth Prospects Highlighted - GuruFocus
Xtant Medical Holdings, Inc. (XTNT) - Minichart
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Growth in Short Interest - MarketBeat
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows By Investing.com - Investing.com Australia
Xtant Medical Holdings, Inc. and Dilon Technologies, Inc Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - marketscreener.com
Xtant Medical Secures Exclusive U.S. Distribution Rights for Dilon’s HEMOBLAST Bellows Hemostatic Product and Expands Sales Team - Minichart
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal - TipRanks
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows - Investing.com
Xtant Medical (XTNT) pays $5M for exclusive U.S. HEMOBLAST rights, adds 20 sales staff - Stock Titan
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - PR Newswire
Breakout Move: Can Xtant Medical Holdings Inc outperform under higher oil pricesTrade Analysis Report & High Win Rate Trade Alerts - baoquankhu1.vn
Sentiment Watch: Is Xtant Medical Holdings Inc stock overvalued or fairly priced2026 EndofYear Setup & Smart Swing Trading Techniques - baoquankhu1.vn
Meme Stocks: Can Xtant Medical Holdings Inc deliver consistent dividends2026 Stock Rankings & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial - Financial Times
Craig-Hallum Maintains Buy on Xtant Medical Holdings, Inc. (XTNT) March 2026 - Meyka
Montana plans donor memorial as 86% of residents register - Stock Titan
XTNT PE Ratio & Valuation, Is XTNT Overvalued - Intellectia AI
XTNT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Craig-Hallum Maintains Buy on Xtant Medical (XTNT) March 18, 2026 - Meyka
Xtant Medical Earnings Call Highlights Profitability Turnaround - The Globe and Mail
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results - Orthopedics This Week
Xtant Medical (NYSEAMERICAN:XTNT) Issues Quarterly Earnings Results - MarketBeat
Xtant Medical Holdings Inc Azioni (XTNT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):